Chapter 17. Antiplatelet Therapy and Coronary Stents

  1. Stephen D. Wiviott MD Assistant Professor Investigator
  1. Alanna Coolong MD, MSc Instructor of Medicine and
  2. Laura Mauri MD, MSc Assistant Professor of Medicine Director of Clinical Biometrics

Published Online: 19 FEB 2009

DOI: 10.1002/9781444303339.ch17

Antiplatelet Therapy In Ischemic Heart Disease

Antiplatelet Therapy In Ischemic Heart Disease

How to Cite

Coolong, A. and Mauri, L. (2008) Antiplatelet Therapy and Coronary Stents, in Antiplatelet Therapy In Ischemic Heart Disease (ed S. D. Wiviott), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303339.ch17

Editor Information

  1. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, TIMI Study Group, Boston, MA, USA

Author Information

  1. Brigham and Women's Hopsital, Harvard Medical School, Boston, MA, USA

Publication History

  1. Published Online: 19 FEB 2009
  2. Published Print: 28 NOV 2008

Book Series:

  1. The AHA Clinical Series

Book Series Editors:

  1. Elliott Antman MD, FAHA

Series Editor Information

  1. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, TIMI Study Group, Boston, MA, USA

ISBN Information

Print ISBN: 9781405176262

Online ISBN: 9781444303339

SEARCH

Keywords:

  • antiplatelet therapy and coronary stents;
  • coronary stenting to prevent abrupt vessel closure and restenosis;
  • Stent Restenosis Study (STRESS);
  • implantation of drug-eluting stents (DES);
  • periprocedural antiplatelet therapy;
  • percutaneous transluminal angioplasty (PTCA);
  • glycoprotein IIb/IIIa inhibitors;
  • Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis (RESTORE) trial;
  • postprocedural antiplatelet therapy;
  • Basel stent cost-effectiveness trial-LAte Thrombotic Events (BASKETLATE)

Summary

This chapter contains sections titled:

  • Introduction

  • Periprocedural antiplatelet therapy

  • Postprocedural antiplatelet therapy

  • References